Study of Tamibarotene in Patients With ADPKD
Clinical trial NCT06289998 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06289998
- Sponsor
- Rege Nephro Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-22
- Primary completion
- 2025-12-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.